CD133+ glioma cells express increased levels of A disintegrin and metalloproteinase 17 (ADAM17) and a disintegrin and metalloproteinase domain‐like protein decysin 1 (ADAMDEC1), two metalloproteinases that degrade ECM proteins and promote stemness in CSCs.158, 159. Here, PROM1 is linked to central nervous system cancer.